Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. & Moayyedi, P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58, 367-378

Gastroenterology Division, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada.
Gut (Impact Factor: 14.66). 12/2008; 58(3):367-78. DOI: 10.1136/gut.2008.163162
Source: PubMed


Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence for treatment of the condition with antidepressants and psychological therapies is conflicting.
Systematic review and meta-analysis of randomised controlled trials (RCTs). MEDLINE, EMBASE and the Cochrane Controlled Trials Register were searched (up to May 2008).
RCTs based in primary, secondary and tertiary care.
Adults with IBS.
Antidepressants versus placebo, and psychological therapies versus control therapy or "usual management".
Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). The number needed to treat (NNT) was calculated from the reciprocal of the risk difference.
The search strategy identified 571 citations. Thirty-two RCTs were eligible for inclusion: 19 compared psychological therapies with control therapy or "usual management", 12 compared antidepressants with placebo, and one compared both psychological therapy and antidepressants with placebo. Study quality was generally good for antidepressant but poor for psychological therapy trials. The RR of IBS symptoms persisting with antidepressants versus placebo was 0.66 (95% CI, 0.57 to 0.78), with similar treatment effects for both tricyclic antidepressants and selective serotonin reuptake inhibitors. The RR of symptoms persisting with psychological therapies was 0.67 (95% CI, 0.57 to 0.79). The NNT was 4 for both interventions.
Antidepressants are effective in the treatment of IBS. There is less high-quality evidence for routine use of psychological therapies in IBS, but available data suggest these may be of comparable efficacy.

Download full-text


Available from: Alexander C Ford,
  • Source
    • "A recent meta-analysis indicates that treatment with either anti-depressant medications or psychological therapies leads to nearly identical improvement rates among IBS patients (relative risks of .66 and .67 respectively) [11]. Despite this, very little research has examined the mechanisms by which the treatment effects of psychological therapies are achieved, and in addition, the magnitude of the relationships between improvements in anxiety and depressive symptoms and improvement in IBS symptoms has not been explored. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Psychological interventions can alleviate the symptoms of irritable bowel syndrome (IBS) and psychological distress commonly reported among IBS sufferers. However, the theoretical underpinnings and intervention techniques used by such interventions vary considerably. This study aimed to identify which theoretical approaches and techniques lead to greater improvements in IBS symptoms and psychological well-being within psychological interventions for IBS. Methods: Outcome data were extracted from 48 randomized controlled trials testing psychological treatments for IBS. Theoretical intervention targets and intervention techniques of each study were identified. Cumulative effect sizes were calculated for pain, bowel dysfunction, composite symptom scores, psychological distress, and health-related quality of life. Comparative analyses contrasted the effect sizes of studies which included each intervention technique to those which did not. Results: Cumulatively, interventions significantly improved all outcomes, with effect sizes (Hedges' g) ranging from 0.32 to 0.64. Interventions which stated a theoretical intervention target, prompted self-monitoring of symptoms and cognitions, provided tailored feedback linking symptoms and cognitions, utilized problem solving or assertiveness training and provided general support had greater effects upon symptom and well-being outcomes than interventions which did not (all P<.05). Across all studies, improvements in psychological distress were associated with improvements in composite symptom scores (P<.01). Conclusions: This study identifies a set of techniques associated with improvements in IBS symptoms and psychological well-being in existing interventions, and provides initial evidence for the link between improvements in psychological distress and IBS composite symptom scores. These findings can aid the development and refinement of psychological treatments for IBS.
    Journal of Psychosomatic Research 12/2014; 78(3). DOI:10.1016/j.jpsychores.2014.12.009 · 2.74 Impact Factor
  • Source
    • "In patients with chronic anxiety, stress (via indirect action on the enteric nervous system) can cause symptoms similar to those found in irritable bowel syndrome [81]. This is in line with the previous models whereby the role of stress and corticotropin-releasing factor act as modulators of the " brain-gut loop " [82], also explaining why antidepressants can be effective in treating gastrointestinal disorders [83]. "

    Behavioural brain research 02/2014; 276. DOI:10.1016/j.bbr.2014.01.038 · 3.03 Impact Factor
  • Source
    • "Irritable bowel syndrome (IBS) affects about 11% of the population [1], is characterized by recurring abdominal pain and diarrhea and/or constipation [2] and associated with decreased quality of life [3] and increased health-care consumption [4]. Several different types of psychological treatments have been studied as interventions for IBS, including cognitive behavior therapy (CBT), psychodynamic therapy, and hypnotherapy [5]. These treatments generally show beneficial effects but treatment effects vary considerably between studies of the same treatment types [6], and little is known about what patient characteristics predict successful outcome from psychological treatment. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several studies show that psychological treatments relieve symptoms for patients suffering from irritable bowel syndrome (IBS). However, there are no consistent findings that show what patient characteristics make a psychological treatment more or less likely to result in improvement. We have previously conducted a study of a newly developed internet-delivered cognitive behavioral therapy (ICBT) that emphasized exposure to IBS symptoms and IBS-related situations and reduced symptom-related avoidance. The study showed that the treatment led to improvement in IBS symptoms compared to a waiting list and that treatment gains were maintained over a 15--18 month follow-up period. The aim of the present study was to investigate several possible predictors of short- and long-term treatment outcome in terms of symptom improvement, based on data collected in the previously conducted treatment trial. Demographics, comorbid psychological distress, IBS-related fear and avoidance behaviors, and IBS-related disability were investigated as predictors of treatment outcome in the sample consisting of 79 participants diagnosed with IBS who had undergone 10 weeks of ICBT. Predictors that were significantly correlated with symptom levels at post-treatment and follow-up were entered into multiple regression analyses that controlled for pre-treatment symptom levels. There were measures within each domain, i.e., comorbid psychological distress, IBS-related fear and avoidance behaviors, and IBS-related disability, with the exception of demographic data, that were correlated with the symptom levels at post-treatment and follow-up. However, when these were entered into a multiple regression analyses that controlled for pre-treatment levels, none remained a significant predictor of the post-treatment and follow-up symptomatic status. The study did not find any individual characteristics that made patients more or less likely to respond to the exposure-based ICBT. The finding that comorbid psychological distress did not predict outcome is in accordance with previous studies. Reliable predictors for response to any type of psychological treatment for IBS remain to be established.
    BMC Gastroenterology 11/2013; 13(1):160. DOI:10.1186/1471-230X-13-160 · 2.37 Impact Factor
Show more